ARCHIVES

Cancer Groups Propose Six Characteristics Of Next FDA Head.

This article is from The Cancer Letter archive.

Vol. 34 No. 46 | December 19, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

June 15, 1979

In Brief: Cancer Program “Strengthened” NIH, Report From Biomedical Research Panel Contends

April 16, 1976

NCI-Approved Clinical Trials

April 29, 2005

Bioassay Report Clears EDTA

August 12, 1977

Letter Protests Closed Meeting; NIH Calls Action Appropriate

August 12, 1994

New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds

June 28, 2002